Israel China Biotechnology (ICB) Ltd (ICB) — Net Asset Momentum
Israel China Biotechnology (ICB) Ltd (ICB) recorded a net asset momentum of -75.1% as of December 2020, with net assets of ILA470.00K ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Israel China Biotechnology (ICB) Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Israel China Biotechnology (ICB) Ltd Net Asset Momentum (2015–2020)
This chart tracks Israel China Biotechnology (ICB) Ltd's year-over-year net asset growth across 6 annual reporting periods from 2015 to 2020. The most recent momentum reading is -75.1%, with net assets of ILA470.00K ILA as of December 2020. Read Israel China Biotechnology (ICB) Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below shows the complete annual net asset history for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see ICB company net worth.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2020 | ILA470.00K | ILA8.34 Million | ILA7.87 Million | ▼ -75.1% |
| 2019 | ILA1.89 Million | ILA11.57 Million | ILA9.68 Million | ▼ -74.5% |
| 2018 | ILA7.41 Million | ILA9.88 Million | ILA2.46 Million | ▲ +539.4% |
| 2017 | ILA-1.69 Million | ILA1.18 Million | ILA2.87 Million | ▼ -188.5% |
| 2016 | ILA1.91 Million | ILA4.06 Million | ILA2.15 Million | ▼ -67.0% |
| 2015 | ILA5.78 Million | ILA8.18 Million | ILA2.39 Million | — |